{"disease":{"id":"advanced-or-unresectable-locally-advanced-bone-and-soft-tissue-sarcoma","name":"advanced or unresectable locally advanced bone and soft tissue sarcoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05941325","title":"A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Shanghai 6th People's Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}